Artykuły udostępnione publicznie: - Dieter SteinhilberWięcej informacji
Niedostępne w żadnym miejscu: 46
5-Lipoxygenase: regulation of expression and enzyme activity
O Rådmark, O Werz, D Steinhilber, B Samuelsson
Trends in biochemical sciences 32 (7), 332-341, 2007
Upoważnienia: German Research Foundation
5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease
O Rådmark, O Werz, D Steinhilber, B Samuelsson
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2015
Upoważnienia: German Research Foundation, Swedish Research Council
Therapeutic options for 5-lipoxygenase inhibitors
O Werz, D Steinhilber
Pharmacology & therapeutics 112 (3), 701-718, 2006
Upoważnienia: German Research Foundation
Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes
D Poeckel, C Greiner, M Verhoff, O Rau, L Tausch, C Hörnig, ...
Biochemical pharmacology 76 (1), 91-97, 2008
Upoważnienia: German Research Foundation
Celecoxib inhibits 5-lipoxygenase
TJ Maier, L Tausch, M Hoernig, O Coste, R Schmidt, C Angioni, J Metzner, ...
Biochemical pharmacology 76 (7), 862-872, 2008
Upoważnienia: German Research Foundation
A dual modulator of farnesoid X receptor and soluble epoxide hydrolase to counter nonalcoholic steatohepatitis
J Schmidt, M Rotter, T Weiser, S Wittmann, L Weizel, A Kaiser, J Heering, ...
Journal of medicinal chemistry 60 (18), 7703-7724, 2017
Upoważnienia: German Research Foundation
5-lipoxygenase is a direct target of miR-19a-3p and miR-125b-5p
S Busch, E Auth, F Scholl, S Huenecke, U Koehl, B Suess, D Steinhilber
The Journal of Immunology 194 (4), 1646-1653, 2015
Upoważnienia: German Research Foundation
Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells?
J Roos, S Grösch, O Werz, P Schröder, S Ziegler, S Fulda, P Paulus, ...
Pharmacology & therapeutics 157, 43-64, 2016
Upoważnienia: German Research Foundation, European Commission
The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes
N Schnur, S Seuter, C Katryniok, O Rådmark, D Steinhilber
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2007
Upoważnienia: German Research Foundation
Apoptotic cancer cells suppress 5-lipoxygenase in tumor-associated macrophages
J Ringleb, E Strack, C Angioni, G Geisslinger, D Steinhilber, A Weigert, ...
The Journal of Immunology 200 (2), 857-868, 2018
Upoważnienia: German Research Foundation
Phytochemicals resveratrol and sulforaphane as potential agents for enhancing the anti-tumor activities of conventional cancer therapies
B M. Kaminski, D Steinhilber, J M. Stein, S Ulrich
Current pharmaceutical biotechnology 13 (1), 137-146, 2012
Upoważnienia: German Research Foundation
l-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ
L Gellrich, P Heitel, J Heering, W Kilu, J Pollinger, T Goebel, A Kahnt, ...
Journal of medicinal chemistry 63 (13), 6727-6740, 2020
Upoważnienia: Genome Canada, Wellcome Trust, European Commission
Synthesis and structure–activity relationship studies of novel dual inhibitors of soluble epoxide hydrolase and 5-lipoxygenase
K Meirer, CB Rödl, JM Wisniewska, S George, AK Häfner, E Buscató, ...
Journal of medicinal chemistry 56 (4), 1777-1781, 2013
Upoważnienia: German Research Foundation
Multi-dimensional target profiling of N, 4-diaryl-1, 3-thiazole-2-amines as potent inhibitors of eicosanoid metabolism
CB Rödl, D Vogt, SBM Kretschmer, K Ihlefeld, S Barzen, A Brüggerhoff, ...
European Journal of Medicinal Chemistry 84, 302-311, 2014
Upoważnienia: German Research Foundation, Fraunhofer-Gesellschaft, European Commission
Cysteinyl leukotriene-receptor-1 antagonists interfere with PGE2 synthesis by inhibiting mPGES-1 activity
AS Kahnt, F Rörsch, O Diehl, B Hofmann, C Lehmann, SD Steinbrink, ...
Biochemical Pharmacology 86 (2), 286-296, 2013
Upoważnienia: German Research Foundation
PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells
I Josipovic, C Fork, J Preussner, KK Prior, D Iloska, AE Vasconez, ...
Acta Physiologica 218 (1), 13-27, 2016
Upoważnienia: German Research Foundation
Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP
AK Häfner, J Gerstmeier, M Hörnig, S George, AK Ball, M Schröder, ...
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2015
Upoważnienia: German Research Foundation
Resveratrol-induced potentiation of the antitumor effects of oxaliplatin is accompanied by an altered cytokine profile of human monocyte-derived macrophages
BM Kaminski, A Weigert, MC Scherzberg, S Ley, B Gilbert, K Brecht, ...
Apoptosis 19, 1136-1147, 2014
Upoważnienia: German Research Foundation
The coding sequence mediates induction of 5-lipoxygenase expression by Smads3/4
S Seuter, BL Sorg, D Steinhilber
Biochemical and biophysical research communications 348 (4), 1403-1410, 2006
Upoważnienia: German Research Foundation
Michael acceptor containing drugs are a novel class of 5-lipoxygenase inhibitor targeting the surface cysteines C416 and C418
IV Maucher, M Ruehl, SBM Kretschmer, B Hofmann, B Kuehn, J Fettel, ...
Biochemical pharmacology 125, 55-74, 2017
Upoważnienia: German Research Foundation, Fraunhofer-Gesellschaft
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy